Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Diseas
Go back to Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Diseas| (NASDAQ: ACER) | Delayed: 0.90 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.90 | 52 Week High | $ | |||
| Open | $0.90 | 52 Week Low | $ | |||
| Day High | $0.90 | P/E | N/A | |||
| Day Low | $0.90 | EPS | $ | |||
| Volume | 10,550 | |||||
| COHEN & STEERS ADVANTAGE INCOME REALTY FUND, INC. COMMON SHARES (NYSE: RLF) | Delayed: 5.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.93 | 52 Week High | $6.30 | |||
| Open | $11.59 | 52 Week Low | $1.47 | |||
| Day High | $5.93 | P/E | N/A | |||
| Day Low | $5.93 | EPS | $0.00 | |||
| Volume | 12,429 | |||||
| (AMEX: RLFTF) | Delayed: 1.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.43 | P/E | N/A | |||
| Day Low | $1.43 | EPS | $ | |||
| Volume | 3,323 | |||||
